MiR‐629 regulates hypoxic pulmonary vascular remodelling by targeting FOXO3 and PERP

Pulmonary arterial hypertension (PAH) is featured by the increase in pulmonary vascular resistance and pulmonary arterial pressure. Despite that abnormal proliferation and phenotypic changes in human pulmonary artery smooth muscle cells (HPASMCs) contributing to the pathophysiology of PAH, the under...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Mei, Chen, Ni, Li, Xuelian, Lin, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653446/
https://www.ncbi.nlm.nih.gov/pubmed/31240850
http://dx.doi.org/10.1111/jcmm.14385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653446/
https://www.ncbi.nlm.nih.gov/pubmed/31240850
http://dx.doi.org/10.1111/jcmm.14385

Ejemplares similares